Akaza Research has been awarded a contract by the National Cancer Institute to develop a Patient Study Calendar module for OpenClinica under the National Cancer Institute’s Cancer Bioinformatics Grid (caBIG) initiative.
Cambridge, MA (PRWEB) June 10, 2006 -- Akaza Research, the developer of OpenClinica™, the leading open source clinical research software, announced today a partnership with Northwestern University and Semantic Bits, LLC to develop software for cancer clinical trials. The group has been awarded a contract by the National Cancer Institute to develop a Patient Study Calendar platform for the National Cancer Institute’s Cancer Bioinformatics Grid (caBIG™) initiative.
The caBIG™ initiative makes critical tools and data accessible to cancer researchers worldwide to speed the development of innovative approaches for cancer prevention and treatment. The cutting-edge infrastructure developed by caBIG™ has broad utility in other disease areas as well.
The Patient Study Calendar module will be a caBIG “silver-level compliant” component that will function in harmony with other caBIG-compliant components. caBIG components are targeted for deployment in all NCI-designated cancer centers.
Key features of the Patient Study Calendar module include:
o Patient screening and registration
o Adaptable schedule definitions
o Prospective forecasting of visit information
o A framework for analyzing historical events
o A security model suitable for multi-site protocols
The module will generate alerts for upcoming events and missed events, track and report dates of anticipated versus actual events, and report on patient accrual, missed events, and schedule deviations.
Types of research set to benefit from this module include disease prevention, therapeutic, observational, correlative, ancillary, screening, diagnostic, and biobanking studies.
About OpenClinica™
OpenClinica™ is an open source web-based software platform that enables sponsors and investigators to manage clinical research data in multi-site studies. It facilitates protocol configuration, design of case report forms, electronic data capture, and study/data management. OpenClinica™ supports HIPAA and 21 CFR Part 11 guidelines and is designed as a fully standards-based, extensible, and modular platform. OpenClinica™ v1.0 was released in October 2005 under the GNU Lesser General Public License (LGPL). See http://www.OpenClinica.org. OpenClinica 2.0 is scheduled to be released in beta this summer.
About Akaza Research
Akaza Research, a leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the leading open source clinical trial data collection and management software platform. Akaza brings Open Source Software solutions to mainstream clinical research by making high quality, standards-based systems accessible for both private and public research. Akaza Research provides support, training, and consulting services to its customers worldwide. See http://www.akazaresearch.com.
MEDIA CONTACT: Steve Glines, sglines @ industrialmyth.com, 978-952-6340
# # #
|
